These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 807313)
1. Treatment of chromophobe adenmas with megavoltage tirradiation. Pistenma DA; Goffinet DR; Bagshaw MA; Hanbery JW; Eltringham JR Cancer; 1975 Jun; 35(6):1574-82. PubMed ID: 807313 [TBL] [Abstract][Full Text] [Related]
2. Surgical experience with chromophobe adenomas of the pituitary gland. Ray BS; Patterson RH J Neurosurg; 1971 Jun; 34(6):726-9. PubMed ID: 5561017 [No Abstract] [Full Text] [Related]
3. Proceedings: Treatment of nonfunctioning chromophobe adenomas of the pituitary. Sheline GE Am J Roentgenol Radium Ther Nucl Med; 1974 Mar; 120(3):553-61. PubMed ID: 4816810 [No Abstract] [Full Text] [Related]
4. The radiotherapy of pituitary chromophobe adenomas: an evaluation of indication, technic, and result. Chang CH; Pool JL Radiology; 1967 Dec; 89(6):1005-16. PubMed ID: 6059621 [No Abstract] [Full Text] [Related]
6. The role of visual fields and visual acuity in the treatment of chromophobe adenoma of the pituitary gland. A case report. Frankelson EN Can J Ophthalmol; 1974 Oct; 9(4):453-7. PubMed ID: 4423942 [No Abstract] [Full Text] [Related]
7. Immunohistochemistry as a predictor of clinical outcome in patients given postoperative radiation for subtotally resected pituitary adenomas. Kovalic JJ; Mazoujian G; McKeel DW; Fineberg BB; Grigsby PW J Neurooncol; 1993 Jun; 16(3):227-32. PubMed ID: 7507978 [TBL] [Abstract][Full Text] [Related]
8. Comparison of results after surgery and after irradiation in pituitary chromophobe adenomas. Svien HJ; Colby MY; Kearns TP Acta Radiol Ther Phys Biol; 1966; 5():53-66. PubMed ID: 5954308 [No Abstract] [Full Text] [Related]
9. Chromophobe adenomas of pituitary gland. Conley JG; Follis CG; Gearhart JP J Ky Med Assoc; 1975 Jan; 73(1):21-4. PubMed ID: 1113020 [No Abstract] [Full Text] [Related]
10. Microsurgical fronto-temporal approach to pituitary adenomas with extrasellar extension. Van Alpen HA Clin Neurol Neurosurg; 1975; 78(4):246-56. PubMed ID: 1234036 [TBL] [Abstract][Full Text] [Related]
11. [Ocular symptomatology of a chromophobe adenoma of the pituitary gland]. Larmande AM; Rossazza C; Delplace MP Rev Otoneuroophtalmol; 1974; 46(4):375-7. PubMed ID: 4445669 [No Abstract] [Full Text] [Related]
12. Stereotactic Curie-therapy of pituitary adenomas. A long-term follow-up study. MUNDINGER F Acta Neurochir (Wien); 1974; Suppl 21():169-76. PubMed ID: 4370389 [No Abstract] [Full Text] [Related]
13. [Visual results of exeresis of pituitary adenomas by the transphenoidal route]. Demailly P; Guiot G; Oproiu A Arch Ophtalmol Rev Gen Ophtalmol; 1967; 27(1):5-34. PubMed ID: 4226500 [No Abstract] [Full Text] [Related]
14. Chromophobe adenoma of pituitary--the silent lesion. A case report. Murray DK Can J Ophthalmol; 1973 Jan; 8(1):164-6. PubMed ID: 4540952 [No Abstract] [Full Text] [Related]
15. The effect of yttrium-90 implantation on endocrine function and visual fields in patients with "functionless" pituitary tumors, with biopsy and radiological findings. Joplin GF; Jackson RA; Arnot RN; Burke CW; Doyle FH; Harsoulis P; Lewis PD; Macerlean DP; Marshall JC; Van Noorden S; Fraser TR Clin Endocrinol (Oxf); 1975 Mar; 4(2):139-63. PubMed ID: 165914 [TBL] [Abstract][Full Text] [Related]